Integer Holdings Co. (NYSE:ITGR) Shares Bought by Congress Asset Management Co.

Congress Asset Management Co. lifted its stake in shares of Integer Holdings Co. (NYSE:ITGR) by 3.9% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 488,785 shares of the medical equipment provider’s stock after buying an additional 18,303 shares during the quarter. Congress Asset Management Co. owned 1.46% of Integer worth $63,542,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Contravisory Investment Management Inc. increased its position in shares of Integer by 55.9% during the third quarter. Contravisory Investment Management Inc. now owns 223 shares of the medical equipment provider’s stock worth $29,000 after acquiring an additional 80 shares during the last quarter. Xponance Inc. increased its holdings in Integer by 4.9% during the 2nd quarter. Xponance Inc. now owns 2,112 shares of the medical equipment provider’s stock worth $245,000 after purchasing an additional 99 shares during the last quarter. Azzad Asset Management Inc. ADV raised its position in shares of Integer by 0.9% in the 3rd quarter. Azzad Asset Management Inc. ADV now owns 11,572 shares of the medical equipment provider’s stock valued at $1,504,000 after purchasing an additional 107 shares in the last quarter. GAMMA Investing LLC boosted its stake in shares of Integer by 60.9% during the 2nd quarter. GAMMA Investing LLC now owns 375 shares of the medical equipment provider’s stock valued at $43,000 after buying an additional 142 shares during the last quarter. Finally, Envestnet Portfolio Solutions Inc. grew its position in shares of Integer by 3.6% during the second quarter. Envestnet Portfolio Solutions Inc. now owns 5,948 shares of the medical equipment provider’s stock worth $689,000 after buying an additional 205 shares in the last quarter. 99.29% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research analysts have commented on ITGR shares. Bank of America increased their price objective on shares of Integer from $135.00 to $145.00 and gave the company a “buy” rating in a research note on Tuesday, October 1st. Piper Sandler reaffirmed an “overweight” rating and set a $140.00 price target (up previously from $125.00) on shares of Integer in a research report on Friday, October 25th. Truist Financial lowered their price objective on Integer from $150.00 to $147.00 and set a “buy” rating for the company in a report on Friday, October 25th. KeyCorp increased their target price on Integer from $139.00 to $144.00 and gave the stock an “overweight” rating in a report on Tuesday, October 15th. Finally, Benchmark boosted their price target on Integer from $130.00 to $140.00 and gave the company a “buy” rating in a report on Monday, October 21st. One investment analyst has rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to MarketBeat.com, Integer currently has an average rating of “Moderate Buy” and a consensus target price of $139.75.

Integer Stock Performance

Shares of ITGR traded down $3.52 during midday trading on Thursday, hitting $126.42. 20,435 shares of the stock traded hands, compared to its average volume of 310,888. The business’s 50 day moving average price is $128.00 and its two-hundred day moving average price is $121.27. The firm has a market capitalization of $4.24 billion, a PE ratio of 44.96, a price-to-earnings-growth ratio of 1.80 and a beta of 1.08. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.96 and a current ratio of 3.29. Integer Holdings Co. has a 1-year low of $79.68 and a 1-year high of $133.53.

Integer (NYSE:ITGR) last posted its earnings results on Thursday, October 24th. The medical equipment provider reported $1.43 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.36 by $0.07. Integer had a net margin of 6.31% and a return on equity of 11.48%. The firm had revenue of $431.42 million during the quarter, compared to analyst estimates of $440.59 million. During the same period in the previous year, the business posted $1.27 EPS. Integer’s revenue was up 8.7% on a year-over-year basis. Equities research analysts predict that Integer Holdings Co. will post 5.3 EPS for the current fiscal year.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.